People who have diabetes will receive an opportunity to learn more about monitors, pumps and other devices during Columbus Community Hospital’s Spring Diabetes Technology Fair. The event will take ...
A new piece of legislation designed to make insulin products more affordable has successfully passed the Oklahoma House and ...
A year to the day after declaring the FDA’s clearance of its automated insulin pump, Sequel Med Tech announced that its first connected continuous glucose monitor will be Abbott’s FreeSty | Greenlit ...
High insulin sensitivity allows the body’s cells to use blood glucose more effectively, reducing blood sugar. Some lifestyle, self-care, and dietary changes may help increase insulin sensitivity.
Hazelight’s Friend’s Pass already makes it easier than ever to play its games with a friend or partner, and you can even try a Split Fiction demo without spending a cent. If you don’t even ...
Marsilla Gray, one of the organizers of the demonstration, which took place across the street from the University of South Florida, said the proposed cuts have created a lot of chaos in her field ...
Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036" report has been added to ResearchAndMarkets.com's offering.
Novo Nordisk A/S and Sanofi are facing an investigation in South Africa over concerns about potential anti-competitive practices in the human insulin pen market. South Africa’s Competition ...
South Africa's competition watchdog probes Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market South Africa’s competition watchdog is investigating ...
Novo’s insulin pen phase-out sparks CompCom probe as diabetes remains a silent killer among SA women
By Janice Kew and Naomi Kresge ___STEADY_PAYWALL___ Novo Nordisk A/S and Sanofi are facing an investigation in South Africa over concerns about potential anti-competitive practices in the human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results